NEW YORK (GenomeWeb) – Myriad Genetics subsidiary Crescendo Bioscience is looking to expand the utility of its Vectra DA rheumatoid arthritis (RA) panel as it works to drive physician adoption and payor coverage of the test.
A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try 360Dx Premium now.
Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.